European Union Regulator Says Benefits Outweigh Risks Of Johnson & Johnson Vaccine

The European Medicines Agency says there is a possible link between the J&J vaccine and rare blood clotting. It says a warning should be added to the label, but says benefits outweigh the risks.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Ad Block Detected

Welcome to Mediexpose, Please support our journalism by allowing ads. With support from readers like you, we can continue to deliver the best. You can support us free by simply allowing ads.